The clinical consequences of SARS-CoV-2 infection in patients with pancreaticoduodenectomy for malignant disease
| Autor: | Alexandru MARTINIUC, Ana STANILA, Daniela TABACELIA, Radu POENARU, Stefana DUMITRAS, Florina A. NITU, Radu DUMITRU, Madalina M. FLORESCU, Raluca R. GRIGORESCU, Cristian ROSIANU, Laura POPA, Adelina BIRCEANU, Dragos CHIRITA, Cezar STROESCU |
|---|---|
| Jazyk: | English<br />French |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Archives of the Balkan Medical Union, Vol 57, Iss 1, Pp 100-105 (2022) |
| Druh dokumentu: | article |
| ISSN: | 1584-9244 2558-815X |
| DOI: | 10.31688/ABMU.2022.57.1.12 |
| Popis: | Introduction. The coronavirus disease 2019 (COVID-19) pandemic has constrained healthcare units to reorganize hospital departments, substantially reducing their capacity to perform oncology-related surgeries. Despite the efforts to reduce the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during hospitalization, COVID-19 has complicated the recovery of many surgical patients. Our objective was to assess the impact of SARS-CoV-2 infection on the postoperative evolution of patients with pancreatic surgery. Cases presentation. We present four patients with pancreaticoduodenectomy for malignant disease, operated in our hepato-biliary-pancreatic surgery department, who presented COVID-19 in the postoperative period, despite initial negative screening. 10% of patients who had pancreaticoduodenectomies were subsequently detected with minimal, moderate to severe forms of COVID-19 in the postoperative period, which led to an extension of the hospitalization period, in some cases, by up to five weeks. Conclusions. The side effects of COVID-19 pandemic are yet to have reached their limits. Pancreaticoduodenectomy is a complex surgery with high morbidity rates, but during the COVID-19 pandemics it has become more challenging. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|